Mobile internet is China's most lucrative sector according to Fosun International, the country's largest private investment firm.» Read More
The family of Henrietta lacks, whose immortal cells made billions in medical research, won an ethical victory when they were given some power over HeLa cell information.
Chinese scientists have discovered the first case of human-to-human transmission of the H7N9 bird flu.
Chinese authorities have visited a site operated by Danish drugmaker Novo Nordisk, the latest evidence of a widening investigation into Western drugmakers.
A major deal could lead to an ironic outcome: more residents in anti-Obama states enrolling in health insurance exchanges than those in pro-Obama states.
The federal government is taking a big step toward letting eHealthInsurance.com, Getinsured.com and other sites enroll people in many Obamacare exchanges.
With Obamacare looming, businesses may look to offer employees healthy-living incentives and track them, said John Sculley, co-founder of Misfit Wearables and former Apple CEO.
People who choose to undergo plastic surgery are looking to shave many years off their appearance. A new study has found that the number of years is smaller than you'd expect.
With 76 million baby boomers reaching retirement age over the next decade, the need for long-term care services is expected to surge. What to do?
Thinking ahead about long-term care can bring big benefits later as the experience of a retired New Jersey teacher shows.
Gina Martin Adams, Senior Equity Strategist at Wells Fargo Securities, says there's one sector that will be a bright spot in the months to come.
Working more could mean thousands of dollars less for you under a quirk in the new health-care law going into effect this fall.
Ted Cruz has outlined a plan to defund Obamacare going forward, but he needs Republicans to stand up and ban together to vote to withdraw financial support of the health-care law.
Community Health Systems announced it would buy Health Management Associates in a deal valued at approximately $7.6 billion, including about $3.7 billion in debt.
Barbara Ryan, FTI Consulting, breaks down the second quarter numbers on Pfizer and Merck and provides an outlook on which companies have the best drugs in the pipeline.
Regardless of what narrative may ultimately prove to best explain GSK's current problems in China, doing business in the sector for multinationals will never be the same.
Merck reported second-quarter earnings on Tuesday that exceeded analysts' expectations, yet revenues fell on weak drug sales.
Pfizer reported earnings slightly ahead of forecasts, as the largest U.S. drugmaker lines up a business split that could lead to the spin-off of its generics division.
Using a technology that echoes science fiction, a company is offering people a place to store their stem cells in a bet that they may one day be used to grow replacement organs.
Both Pfizer and Merck are expected to report double-digit declines in top- and bottom-line growth when they announce earnings Tuesday.
U.S. generic drugmaker Perrigo agreed to buy fellow drug company Elan for $8.6 billion on Monday in a deal that will hand it royalty rights from a blockbuster treatment and tax savings from being domiciled in Ireland.
Get the best of CNBC in your inbox